Cargando…

H(2)S- and NO-Signaling Pathways in Alzheimer's Amyloid Vasculopathy: Synergism or Antagonism?

Alzheimer's type of neurodegeneration dramatically affects H(2)S and NO synthesis and interactions in the brain, which results in dysregulated vasomotor function, brain tissue hypoperfusion and hypoxia, development of perivascular inflammation, promotion of Aβ deposition, and impairment of neur...

Descripción completa

Detalles Bibliográficos
Autores principales: Salmina, Alla B., Komleva, Yulia K., Szijártó, István A., Gorina, Yana V., Lopatina, Olga L., Gertsog, Galina E., Filipovic, Milos R., Gollasch, Maik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4675996/
https://www.ncbi.nlm.nih.gov/pubmed/26696896
http://dx.doi.org/10.3389/fphys.2015.00361
Descripción
Sumario:Alzheimer's type of neurodegeneration dramatically affects H(2)S and NO synthesis and interactions in the brain, which results in dysregulated vasomotor function, brain tissue hypoperfusion and hypoxia, development of perivascular inflammation, promotion of Aβ deposition, and impairment of neurogenesis/angiogenesis. H(2)S- and NO-signaling pathways have been described to offer protection against Alzheimer's amyloid vasculopathy and neurodegeneration. This review describes recent developments of the increasing relevance of H(2)S and NO in Alzheimer's disease (AD). More studies are however needed to fully determine their potential use as therapeutic targets in Alzheimer's and other forms of vascular dementia.